Ansa Biotechnologies
Emeryville
About Ansa Biotechnologies
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $129.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: ansabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ansa-biotechnologies-58212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.